• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    What Procter & Gamble Shares Means For Shareholders

    Simply Wall St·10/25/2026 12:25:02
    Listen to the news
    • Procter & Gamble reported fiscal Q1 2027 sales of US$23,276 million and net income of US$4,731 million, with diluted EPS from continuing operations of US$1.97, alongside reaffirmed full year guidance that factors in higher commodity, interest and FX headwinds.
    • The 2027 outlook now reflects the Thorne acquisition, tightened cost pressure assumptions and continued investment behind new products from brands such as Crest, Head & Shoulders and Charmin, which together highlight how P&G is trying to balance volume growth with margin resilience.
    • The focus now shifts to how Procter & Gamble’s earnings resilience and updated 2027 guidance shape the broader investment narrative.

    See how Procter & Gamble’s mix of steady earnings, brand investment and cost headwinds compares with other mature compounders in our 30 resilient stocks with low risk scores.

    Procter & Gamble Investment Narrative Recap

    To own Procter & Gamble, you need to be comfortable with a slow and steady profile. The bet is that modest organic sales growth, disciplined cost control and a wide brand portfolio together keep earnings supportable even when input costs bite. The latest quarter fits that picture. Sales were higher, net income was roughly flat and EPS from continuing operations held close to last year.

    The key short term swing factor is whether productivity and pricing can offset the US$1.4b commodity and macro headwind built into the 2027 outlook. Management reaffirmed guidance despite that drag, so the near term catalyst is simple delivery against those targets. The main risk is that retailer inventory noise or further cost inflation weakens that execution story.

    The most relevant fresh data point is P&G’s reaffirmed fiscal 2027 earnings framework after acquiring Thorne. Management still guides to 1% to 3% organic sales growth and 1% to 5% diluted EPS growth off US$6.62, even with an estimated US$0.79 per share hit from commodities, interest, non operating items and FX.

    That commitment puts more weight on execution in the core business. Brand launches such as Crest Sensitivity Relief, the new Head & Shoulders Scalp Care Collection and Charmin Ultra Strong with wider sheets all need to support volumes and mix. If these products gain traction, they can help offset cost pressure and support the case that Procter & Gamble can grind out low single digit EPS progress despite a tougher input backdrop.

    Procter & Gamble's current earnings are about US$15.7b and analysts expect earnings to reach US$18.5b by 2029. This implies an earnings increase of roughly US$2.8b from today, alongside forecast revenue of US$96.2b in that same year and an assumed 3.1% yearly revenue growth rate.

    Uncover why Procter & Gamble's fair value indicates a 6% potential upside to its current price that could narrow quickly.

    NYSE:PG 1-Year Stock Price Chart
    NYSE:PG 1-Year Stock Price Chart

    Exploring Other Perspectives

    The Simply Wall St Community has 17 fair value estimates on Procter & Gamble, ranging from US$107.52 at the low end to US$211.07 at the top, so retail opinions span almost a 2x range. When you layer that onto P&G’s reaffirmed 2027 guidance and sizable US$1.4b cost headwind, you get sharply different conclusions about how resilient future earnings could be. Use that spread as a prompt to explore multiple viewpoints rather than relying on a single narrative.

    Explore 16 other Procter & Gamble fair value estimates, including one that suggests as much as 33% downside from the current price.

    The Verdict Is Yours

    Don't just follow the ticker; dig into the data and build a conviction that's truly your own.

    Looking For More Ideas Beyond Procter & Gamble?

    If this Procter & Gamble review has you thinking about portfolio balance, use the Simply Wall St Screener to surface other businesses that match the kind of risk, return and quality profile you are aiming for.

    • For investors who want resilience first and are happy to accept steadier return potential, scan a curated set of 30 resilient stocks with low risk scores that focus on stability and lower volatility.
    • If value is your priority and you are hunting for companies where quality fundamentals meet more modest expectations, comb through our 29 high quality undervalued stocks that highlight stocks priced below their estimated worth on key metrics.
    • Income focused readers who want cash returns today rather than only relying on future price moves can review a hand picked 5 dividend fortresses built around yields of 5% or higher.